Evotec AG (NASDAQ:EVTCY) | WebDisclosure

Basculer en Français

8295	Companies
114850	Keywords
55292	Articles
62440	Press releases

Home
Companies
Evotec AG

BRIEF

published on 10/30/2024 at 08:15, 22 days 3 hours ago

Evotec SE to Release Nine-Month 2024 Financial Results

Financial Results Conference Call Evotec SE Strategic Review Therapeutics Development
PRESS RELEASE

published on 10/30/2024 at 08:10, 22 days 3 hours ago

Evotec SE to announce results for the first nine months 2024 on 06 November 2024
Evotec SE to announce financial results for the first nine months of 2024 on 06 November 2024, including conference call discussing strategic review process

Financial Results Conference Call Evotec SE Life Science Strategic Review
BRIEF

published on 10/23/2024 at 07:34, 29 days 4 hours ago

Evotec et Bristol Myers Squibb renforcent leur collaboration en protéomique

Bristol Myers Squibb Dégradeurs De Colle Moléculaire Découverte De Médicaments Partenariat En Protéomique Collaboration Evotec
BRIEF

published on 10/23/2024 at 07:34, 29 days 4 hours ago

Evotec and Bristol Myers Squibb Strengthen Proteomics Collaboration

Drug Discovery Bristol Myers Squibb Molecular Glue Degraders Proteomics Partnership Evotec Collaboration
PRESS RELEASE

published on 10/23/2024 at 07:29, 29 days 4 hours ago

Evotec and Bristol Myers Squibb expand proteomics partnership
Evotec SE and Bristol Myers Squibb expand proteomics partnership, advancing molecular glue degraders beyond oncology. Evotec receives US$50m payment

Evotec SE Oncology Bristol Myers Squibb Molecular Glue Degraders Proteomics Partnership
BRIEF

published on 09/26/2024 at 07:35, 1 month 25 days ago

Evotec and Novo Nordisk Enter Partnership for Next-Generation Cell Therapies

Partnership Cell Therapy Stem Cells Evotec Novo Nordisk
BRIEF

published on 09/26/2024 at 07:35, 1 month 25 days ago

Evotec et Novo Nordisk concluent un partenariat pour les thérapies cellulaires de nouvelle génération

Partenariat Thérapie Cellulaire Cellules Souches Evotec Novo Nordisk
PRESS RELEASE

published on 09/26/2024 at 07:30, 1 month 25 days ago

Evotec and Novo Nordisk enter into technology development partnership to support next-generation cell therapies
Evotec and Novo Nordisk partner for next-gen cell therapies. Novo Nordisk funds Evotec for tech development in stem cell-based therapies, aiming for clinical and commercial success

Partnership Evotec Technology Development Novo Nordisk Cell Therapies
BRIEF

published on 09/20/2024 at 15:34, 2 months ago

Evotec SE Opens J.POD® Biologics Facility in Toulouse, France

Sustainability Evotec Toulouse Biologics J.POD®
BRIEF

published on 09/20/2024 at 15:34, 2 months ago

Evotec SE ouvre une usine de produits biologiques J.POD® à Toulouse, en France

Durabilité Evotec Produits Biologiques Toulouse J.POD®

Accesswire

Published on 11/21/2024 at 11:30, 28 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 1 hour 55 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 58 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 58 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 23 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 11:30, 28 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 57 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 58 minutes ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 1 hour 1 minute ago

ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 28 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024

Les Echos

Published on 11/21/2024 at 06:58, 5 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 50 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 38 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE